253 related articles for article (PubMed ID: 2542618)
1. The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle.
Rooney CM; Rowe DT; Ragot T; Farrell PJ
J Virol; 1989 Jul; 63(7):3109-16. PubMed ID: 2542618
[TBL] [Abstract][Full Text] [Related]
2. The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.
Kenney S; Kamine J; Holley-Guthrie E; Lin JC; Mar EC; Pagano J
J Virol; 1989 Apr; 63(4):1729-36. PubMed ID: 2538653
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
Le Roux F; Sergeant A; Corbo L
J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
5. Characterization of proteins encoded by the Epstein-Barr virus transactivator gene BMLF1.
Wong KM; Levine AJ
Virology; 1989 Jan; 168(1):101-11. PubMed ID: 2535897
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.
Buisson M; Manet E; Trescol-Biemont MC; Gruffat H; Durand B; Sergeant A
J Virol; 1989 Dec; 63(12):5276-84. PubMed ID: 2555554
[TBL] [Abstract][Full Text] [Related]
7. Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions.
Lieberman PM; Hardwick JM; Hayward SD
J Virol; 1989 Jul; 63(7):3040-50. PubMed ID: 2542612
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
9. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.
Gradoville L; Grogan E; Taylor N; Miller G
Virology; 1990 Oct; 178(2):345-54. PubMed ID: 2171186
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency.
Jenson HB; Miller G
Virology; 1988 Aug; 165(2):549-64. PubMed ID: 2841800
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.
Kenney S; Holley-Guthrie E; Mar EC; Smith M
J Virol; 1989 Sep; 63(9):3878-83. PubMed ID: 2548003
[TBL] [Abstract][Full Text] [Related]
12. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
13. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
14. Structure and function of the Epstein-Barr virus BZLF1 protein.
Packham G; Economou A; Rooney CM; Rowe DT; Farrell PJ
J Virol; 1990 May; 64(5):2110-6. PubMed ID: 2157874
[TBL] [Abstract][Full Text] [Related]
15. Strain variation in Epstein-Barr virus immediate early genes.
Packham G; Brimmell M; Cook D; Sinclair AJ; Farrell PJ
Virology; 1993 Feb; 192(2):541-50. PubMed ID: 8093650
[TBL] [Abstract][Full Text] [Related]
16. Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency.
Rooney C; Taylor N; Countryman J; Jenson H; Kolman J; Miller G
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9801-5. PubMed ID: 2849118
[TBL] [Abstract][Full Text] [Related]
17. Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses.
Taylor N; Countryman J; Rooney C; Katz D; Miller G
J Virol; 1989 Apr; 63(4):1721-8. PubMed ID: 2538652
[TBL] [Abstract][Full Text] [Related]
18. Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.
Chevallier-Greco A; Manet E; Chavrier P; Mosnier C; Daillie J; Sergeant A
EMBO J; 1986 Dec; 5(12):3243-9. PubMed ID: 3028777
[TBL] [Abstract][Full Text] [Related]
19. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.
Needham J; Adamson AL
Virus Genes; 2019 Dec; 55(6):779-785. PubMed ID: 31552622
[TBL] [Abstract][Full Text] [Related]
20. The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions.
Lieberman PM; Hardwick JM; Sample J; Hayward GS; Hayward SD
J Virol; 1990 Mar; 64(3):1143-55. PubMed ID: 2154599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
